Your browser doesn't support javascript.
loading
Tocilizumab in Giant Cell Arteritis: Better Understanding the Benefits.
Buttgereit, Frank; Palmowski, Andriko; Esen, Idil; Brouwer, Elisabeth.
Affiliation
  • Buttgereit F; Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Rheumatology and Clinical Immunology, Berlin, Germany.
  • Palmowski A; Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Rheumatology and Clinical Immunology, Berlin, Germany, Section for Biostatistics and Evidence-Based Research, The Parker Institute, University of Copenhagen, Copenhage
  • Esen I; Department of Rheumatology and Clinical Immunology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
  • Brouwer E; Department of Rheumatology and Clinical Immunology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Arthritis Rheumatol ; 75(4): 489-492, 2023 04.
Article in En | MEDLINE | ID: mdl-36468520
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Giant Cell Arteritis Limits: Humans Language: En Journal: Arthritis Rheumatol Year: 2023 Document type: Article Affiliation country: Alemania
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Giant Cell Arteritis Limits: Humans Language: En Journal: Arthritis Rheumatol Year: 2023 Document type: Article Affiliation country: Alemania